Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
********************************************************************
THE ME-P DISCLAIMER: Posts, comments and all opinions do not necessarily represent iMBA, Inc.
Life Science Startups Rising in the UK
Stephen Chambers spent 22 years in some of the most innovative companies in life science as the director of gene expression and then as a co-founder of his own company.
Today he runs SynbiCITE, the UK’s synthetic biology consortium of 56 industrial partners and 19 Academic institutions located at Imperial College in London.
Stephen and SynbiCITE, just launched the world’s first Lean LaunchPad for Synthetic Biology program.
Here’s his story.
By Steve Blank
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
- Dictionary of Health Economics and Finance
- Dictionary of Health Information Technology and Security
- Dictionary of Health Insurance and Managed Care
Share this:
Filed under: Career Development, Research & Development | Tagged: business incubators, Life Science Startups Rising, Stephen Chambers, Steve Blank, SynbiCITE |
“A digital disruption is playing out in healthcare, as witnessed by the emergence of new business models and technology that will change the nature of patient interactions, alter consumer expectations and ultimately improve health outcomes.”
Rick Ratliff
[Managing Director Of Digital Health Solutions]
Accenture
LikeLike
Start-Ups Rising
I do believe that start-up plans can succeed in the current market environment. Having said this, failures have been common. My favorite model for successful startups are new health plans serving Medicare Advantage members that are linked to health systems.
To be successful any health plan has to offer lower costs, higher perceived value and overcome distribution barriers. MA plans linked to health systems offer the possibility of lower costs through integrated care, a “halo of quality” from the associated health system and, since the MA product is sold to the individual market, is intrinsically beyond the confines of the employer-based market.
Realizing success depends on excellence in execution. Effective execution requires either the rethinking of the health system’s business model, or at least a commitment that the health plan should maintain operating its integrity. That there have been many failures among health system sponsored plans indicates that this is easier said than done.
Douglas Sherlock CFA
[Senior Health Care Analyst]
Sherlock Company
LikeLike
Questionable “Young Blood” Transfusions Offered in U.S. as Anti-Aging Remedy
A startup called Ambrosia will fill your veins with the blood of young people and empty your pockets of $8,000.
https://www.technologyreview.com/s/603242/questionable-young-blood-transfusions-offered-in-us-as-anti-aging-remedy/?utm_source=MIT+TR+Newsletters&utm_campaign=b1d4b8bc6a-The_Download&utm_medium=email&utm_term=0_997ed6f472-b1d4b8bc6a-154253973
Ann Miller RN MHA
LikeLike